RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke pts https://t.co/Wy9YTw9573 Now MORE proof in #JACCJournals. 201 w/cryptogenic embolism https://t.co/X84Y8j99gD #EchoFirst #PFO https://t.co/xYv1rX2Tuj
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – Dec 2024Where it's discussed
-
X / Twitter75 posts
-
News22 articles
-
Facebook11 posts
-
Blogs5 articles
-
YouTube2 videos
AI synopsis
What people are saying
The social discussions consistently emphasize the positive implications of the research, citing examples like extended follow-up results and the reduction in recurrent strokes, using enthusiastic language such as 'demostraron beneficio' and 'more proof,' which reflect high regard and engagement. The tone suggests that participants perceive the study as influential and meaningful for clinical practice.
Most discussions support the study’s findings that PFO closure reduces stroke recurrence, emphasizing the benefits shown in trials like RESPECT.
Participants are highly engaged, referencing details like long-term follow-up results and clinical implications, indicating strong interest in the topic.
Comments include reflections on the significance of extended observation periods and implications for clinical practice, showing active engagement.
The discussions highlight the potential for changing treatment protocols and improving patient outcomes, suggesting a noticeable impact.
Abstract in brief
- The study investigated whether closing a patent foramen ovale (PFO) reduces the risk of recurrent ischemic strokes in patients who previously experienced a cryptogenic stroke, comparing PFO closure to medical therapy over an extended follow-up period.
- Results showed that patients who underwent PFO closure had a lower rate of recurrent ischemic strokes (0.58 per 100 patient-years) compared to those receiving medical therapy (1.07 per 100 patient-years), indicating a potential benefit of PFO closure.
- The findings suggest that PFO closure may significantly reduce recurrence risk, especially for strokes of undetermined cause, with hazard ratios indicating nearly a 60-70% reduction in hazard compared to medical therapy.]
Top posts
Most liked on X and Blueskyhttps://t.co/y0Ah0B8mzH
Extender el período de observación del RESPECT Trial a 10 años lo convierte en una cohorte y sus resultados exploratorios. Demostraron beneficio. https://t.co/xbDP7NLFa8
@J_Rosales_MD @WorldStrokeEd @vascularnotes @sheilambrasil If you have PFO with high risk features would close given data from long term 6 yr follow up of respect trial https://t.co/bbH6nigs3a
@ProfMattFox A positive step, yes, but will it change the problem of binary thinking? I'm worried that we'll just see more papers with 95% CI limits of 1.001 or 0.999, like this one from a couple of years ago: https://t.co/sp80J57ZBg https://t.co/0owbPao34f
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
All mentions
Patent Foramen Ovale and Stroke Prevention: Clinical Guidelines Update
This video discusses recent updates on PFO management for secondary stroke prevention, including clinical guidelines and outcomes of medical therapy versus closure, highlighting key insights from leading neurological…
Patent Foramen Ovale and Stroke Prevention: Clinical Guidelines Update
This video discusses the latest clinical guidelines on managing patent foramen ovale to prevent secondary stroke, highlighting recent research and recommended practices for healthcare professionals.
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @jsenior64: Extender el período de observación del RESPECT Trial a 10 años lo convierte en una cohorte y sus resultados exploratorios. D…
Extender el período de observación del RESPECT Trial a 10 años lo convierte en una cohorte y sus resultados exploratorios. Demostraron beneficio. https://t.co/xbDP7NLFa8
RT @DrDamluji: https://t.co/y0Ah0B8mzH
https://t.co/y0Ah0B8mzH
@J_Rosales_MD @WorldStrokeEd @vascularnotes @sheilambrasil If you have PFO with high risk features would close given data from long term 6 yr follow up of respect trial https://t.co/bbH6nigs3a
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
@ProfMattFox A positive step, yes, but will it change the problem of binary thinking? I'm worried that we'll just see more papers with 95% CI limits of 1.001 or 0.999, like this one from a couple of years ago: https://t.co/sp80J57ZBg https://t.co/0owbPao34f
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke | NEJM https://t.co/Ld8Gqhk3v0 https://t.co/Gavt8FeTto
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
El cierre del FOP reduce el embolismo https://t.co/yUR9QO3eD4
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RT @hahn_rt: RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke…
RESPECT trial 980 pts showed closure of patent foramen ovale reduces risk of recurrent stroke in cryptogenic ischemic stroke pts https://t.co/Wy9YTw9573 Now MORE proof in #JACCJournals. 201 w/cryptogenic embolism https://t.co/X84Y8j99gD #EchoFirst #PFO https://t.co/xYv1rX2Tuj
R
AP
JS
SM
SH
DP
DG
EM
DF
L
JF
TF
I
EG
IP
YH
S
RB
GK
CS
سا
R
DP
M
DM
GH
AP
NM
PM
MR
AF
JM
AM
WM
BK
D
GM
E
MO
JK
PF
CE
VM
RM
MM
DV
DB
DV
E
RE
AM
BA
HL
FP
MG
CC
YM
MG
IS
AE
RM
PP
PF
EM
JA
JT
AM
JH
WM
RG
MP
AE